col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


66 Results       Page 1

 [1] 
The Rockefeller University Press: The Journal of Experimental Medicine
  original article Date Title Authors   All Authors
1 [GO] 2025―Oct―09 Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2 Siriruk Changrob, Atsuhiro Yasuhara, Suncheol Park, Sandhya Bangaru, Lei Li, Chloe A. Troxell, et al. (+24)
2 [GO] 2025―Jul―17 In vivo antibody diversification targeting a conserved coronavirus epitope Usha Nair, Ziqi Feng, Madhav Akauliya, Abigail G. Esposito, Charles R. Crain, Edward D. Lamperti, et al. (+9)
3 [GO] 2025―Apr―14 Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains Fanny Saidoune, Danyel Lee, Jeremy Di Domizio, Corentin Le Floc’h, Raphael Jenelten, Jérémie Le Pen, et al. (+13)
4 [GO] 2025―Feb―26 Correction: Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling Benjamin Israelow, Eric Song, Tianyang Mao, Peiwen Lu, Amit Meir, Feimei Liu, et al. (+7)
5 [GO] 2024―Jul―18 SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency Yi-Hao Chan, Vanja Lundberg, Jérémie Le Pen, Jiayi Yuan, Danyel Lee, Francesca Pinci, et al. (+94)
6 [GO] 2024―Jul―01 Kids’ noses resist COVID-19 Ivan Zanoni
7 [GO] 2024―Apr―10 Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung Timothy Ting-Hsuan Wu, Kyle J. Travaglini, Arjun Rustagi, Duo Xu, Yue Zhang, Leonid Andronov, et al. (+19)
8 [GO] 2024―Jan―04 Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children Paul Bastard, Adrian Gervais, Maki Taniguchi, Liisa Saare, Karita Särekannu, Tom Le Voyer, et al. (+294)
9 [GO] 2023―Jun―16 Mammalian infections with highly pathogenic avian influenza viruses renew concerns of pandemic potential Brad Gilbertson, Kanta Subbarao
10 [GO] 2023―May―03 SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19 Ksenia Rybkina, Joseph N. Bell, Marissa C. Bradley, Teddy Wohlbold, Marika Scafuro, Wenzhao Meng, et al. (+11)
11 [GO] 2023―Mar―07 Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia Ana García-García, Rebeca Pérez de Diego, Carlos Flores, Darawan Rinchai, Jordi Solé-Violán, Àngela Deyà-Martínez, et al. (+157)
12 [GO] 2022―Dec―13 Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees Takeshi Inoue, Ryo Shinnakasu, Chie Kawai, Hiromi Yamamoto, Shuhei Sakakibara, Chikako Ono, et al. (+14)
13 [GO] 2022―Nov―07 Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination Aurélien Sokal, Paul Bastard, Pascal Chappert, Giovanna Barba-Spaeth, Slim Fourati, Alexis Vanderberghe, et al. (+46)
14 [GO] 2022―Nov―03 SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly Anna Onnis, Emanuele Andreano, Chiara Cassioli, Francesca Finetti, Chiara Della Bella, Oskar Staufer, et al. (+6)
15 [GO] 2022―Sep―23 Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans Zijun Wang, Pengcheng Zhou, Frauke Muecksch, Alice Cho, Tarek Ben Tanfous, Marie Canis, et al. (+22)
16 [GO] 2022―Sep―21 Impaired immune response drives age-dependent severity of COVID-19 Julius Beer, Stefania Crotta, Angele Breithaupt, Annette Ohnemus, Jan Becker, Benedikt Sachs, et al. (+14)
17 [GO] 2022―Aug―29 Correction: IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2 Malika Hale, Jason Netland, Yu Chen, Christopher D. Thouvenel, Katherine Nabel Smith, Lucille M. Rich, et al. (+14)
18 [GO] 2022―Aug―25 Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens Zijun Wang, Frauke Muecksch, Friederike Muenn, Alice Cho, Shuai Zong, Raphael Raspe, et al. (+24)
19 [GO] 2022―Aug―16 SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity Joey Ming Er Lim, Anthony Tanoto Tan, Nina Le Bert, Shou Kit Hang, Jenny Guek Hong Low, Antonio Bertoletti
20 [GO] 2022―Aug―08 IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2 Malika Hale, Jason Netland, Yu Chen, Christopher D. Thouvenel, Katherine Nabel Smith, Lucille M. Rich, et al. (+14)
21 [GO] 2022―Jul―07 Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants Marianna Agudelo, Frauke Muecksch, Dennis Schaefer-Babajew, Alice Cho, Justin DaSilva, Eva Bednarski, et al. (+20)
22 [GO] 2022―Jul―01 Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans Alice Cho, Frauke Muecksch, Zijun Wang, Tarek Ben Tanfous, Justin DaSilva, Raphael Raspe, et al. (+18)
23 [GO] 2022―Jun―16 Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia Qian Zhang, Daniela Matuozzo, Jérémie Le Pen, Danyel Lee, Leen Moens, Takaki Asano, et al. (+167)
24 [GO] 2022―Jun―15 Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2 Cyril Planchais, Ignacio Fernández, Timothée Bruel, Guilherme Dias de Melo, Matthieu Prot, Maxime Beretta, et al. (+126)
25 [GO] 2022―Apr―14 SARS-CoV-2 infection relaxes peripheral B cell tolerance Moriah J. Castleman, Megan M. Stumpf, Nicholas R. Therrien, Mia J. Smith, Kelsey E. Lesteberg, Brent E. Palmer, et al. (+6)
26 [GO] 2021―Dec―10 Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge Kerry L. Hilligan, Sivaranjani Namasivayam, Chad S. Clancy, Danielle O’Mard, Sandra D. Oland, Shelly J. Robertson, et al. (+9)
27 [GO] 2021―Nov―11 A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice Tianyang Mao, Benjamin Israelow, Carolina Lucas, Chantal B.F. Vogels, Maria Luisa Gomez-Calvo, Olga Fedorova, et al. (+19)
28 [GO] 2021―Oct―20 Correction: Mapping and role of T cell response in SARS-CoV-2-infected mice Zhen Zhuang, Xiaomin Lai, Jing Sun, Zhao Chen, Zhaoyong Zhang, Jun Dai, et al. (+22)
29 [GO] 2021―Oct―18 Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients Xiuyuan Lu, Yuki Hosono, Masamichi Nagae, Shigenari Ishizuka, Eri Ishikawa, Daisuke Motooka, et al. (+24)
30 [GO] 2021―Oct―10 Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses Ryo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, Po-hung Wang, Saya Moriyama, Nicolas Sax, et al. (+13)
31 [GO] 2021―Aug―23 The early interferon catches the SARS-CoV-2 Thomas Decker
32 [GO] 2021―Aug―20 Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs Jonathan Lopez, Marine Mommert, William Mouton, Andrés Pizzorno, Karen Brengel-Pesce, Mehdi Mezidi, et al. (+17)
33 [GO] 2021―Aug―06 Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs Jonathan Lopez, Marine Mommert, William Mouton, Andrés Pizzorno, Karen Brengel-Pesce, Mehdi Mezidi, et al. (+17)
34 [GO] 2021―Jun―21 Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics Nagarjuna R. Cheemarla, Timothy A. Watkins, Valia T. Mihaylova, Bao Wang, Dejian Zhao, Guilin Wang, et al. (+2)
35 [GO] 2021―Jun―15 Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19 Aaron J. Wilk, Madeline J. Lee, Bei Wei, Benjamin Parks, Ruoxi Pi, Giovanny J. Martínez-Colón, et al. (+63)
36 [GO] 2021―Apr―28 SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease? Vanessa Sancho-Shimizu, Petter Brodin, Aurélie Cobat, Catherine M. Biggs, Julie Toubiana, Carrie L. Lucas, et al. (+145)
37 [GO] 2021―Apr―23 Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1 Paul Bastard, Elizaveta Orlova, Leila Sozaeva, Romain Lévy, Alyssa James, Monica M. Schmitt, et al. (+59)
38 [GO] 2021―Apr―20 SARS-CoV-2 spike therapeutic antibodies in the age of variants Alina Baum, Christos A. Kyratsous
39 [GO] 2021―Apr―17 Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection Ross M. Kedl
40 [GO] 2021―Apr―09 Highlights from a year in a pandemic Miriam Merad, Nicolas Vabret
41 [GO] 2021―Mar―19 Lasting memories of SARS-CoV-2 infection Maya M.L. Poon, Donna L. Farber
42 [GO] 2021―Mar―03 Immunodominant antibody germlines in COVID-19 Emanuele Andreano, Rino Rappuoli
43 [GO] 2021―Mar―01 Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection Nina Le Bert, Hannah E. Clapham, Anthony T. Tan, Wan Ni Chia, Christine Y.L. Tham, Jane M. Lim, et al. (+22)
44 [GO] 2021―Jan―28 SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4 Fanny Onodi, Lucie Bonnet-Madin, Laurent Meertens, Léa Karpf, Justine Poirot, Shen-Ying Zhang, et al. (+10)
45 [GO] 2021―Jan―27 Persistent cellular immunity to SARS-CoV-2 infection Gaëlle Breton, Pilar Mendoza, Thomas Hägglöf, Thiago Y. Oliveira, Dennis Schaefer-Babajew, Christian Gaebler, et al. (+4)
46 [GO] 2021―Jan―19 Mapping and role of T cell response in SARS-CoV-2-infected mice Zhen Zhuang, Xiaomin Lai, Jing Sun, Zhao Chen, Zhaoyong Zhang, Jun Dai, et al. (+22)
47 [GO] 2021―Jan―14 Neuroinvasion of SARS-CoV-2 in human and mouse brain Eric Song, Ce Zhang, Benjamin Israelow, Alice Lu-Culligan, Alba Vieites Prado, Sophie Skriabine, et al. (+33)
48 [GO] 2020―Dec―09 COVID-19 stokes inflammasomes Clare Bryant
49 [GO] 2020―Dec―02 Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients Tamara S. Rodrigues, Keyla S.G. de Sá, Adriene Y. Ishimoto, Amanda Becerra, Samuel Oliveira, Leticia Almeida, et al. (+38)
50 [GO] 2020―Nov―23 Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo Alexandra Schäfer, Frauke Muecksch, Julio C.C. Lorenzi, Sarah R. Leist, Melissa Cipolla, Stylianos Bournazos, et al. (+12)
51 [GO] 2020―Oct―16 SARS-CoV-2 vaccine development, access, and equity Jerome H. Kim
52 [GO] 2020―Oct―13 An unconventional view of COVID-19 T cell immunity Hui-Fern Koay, Thomas S. Fulford, Dale I. Godfrey
53 [GO] 2020―Sep―29 An ace model for SARS-CoV-2 infection Jack Major, Andreas Wack
54 [GO] 2020―Sep―14 Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19 Coraline Radermecker, Nancy Detrembleur, Julien Guiot, Etienne Cavalier, Monique Henket, Céline d’Emal, et al. (+5)
55 [GO] 2020―Sep―14 SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology Flavio Protasio Veras, Marjorie Cornejo Pontelli, Camila Meirelles Silva, Juliana E. Toller-Kawahisa, Mikhael de Lima, Daniele Carvalho Nascimento, et al. (+40)
56 [GO] 2020―Sep―10 Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies Ting Zhou, Tina Tianjiao Su, Tenny Mudianto, Jun Wang
57 [GO] 2020―Sep―04 Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients Youenn Jouan, Antoine Guillon, Loïc Gonzalez, Yonatan Perez, Chloé Boisseau, Stephan Ehrmann, et al. (+8)
58 [GO] 2020―Aug―04 Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling Benjamin Israelow, Eric Song, Tianyang Mao, Peiwen Lu, Amit Meir, Feimei Liu, et al. (+7)
59 [GO] 2020―Jul―31 Lessons of COVID-19: A roadmap for post-pandemic science Tanya S. Freedman, Mark B. Headley, Nina Serwas, Megan Ruhland, Carlos A. Castellanos, Alexis J. Combes, Matthew F. Krummel
60 [GO] 2020―Jul―31 Lessons of COVID-19: Virtual conferences Stephanie Houston
61 [GO] 2020―Jul―21 Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Julio C.C. Lorenzi, et al. (+15)
62 [GO] 2020―Jul―17 Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19 Lars M. Koenig, Daniel F.R. Boehmer, Philipp Metzger, Max Schnurr, Stefan Endres, Simon Rothenfusser
63 [GO] 2020―Jul―17 Neutrophils and COVID-19: Nots, NETs, and knots Carl Nathan
64 [GO] 2020―Jun―18 The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications Betty Diamond
65 [GO] 2020―Apr―16 Targeting potential drivers of COVID-19: Neutrophil extracellular traps Betsy J. Barnes, Jose M. Adrover, Amelia Baxter-Stoltzfus, Alain Borczuk, Jonathan Cools-Lartigue, James M. Crawford, et al. (+17)
66 [GO] 2020―Apr―14 COVID-19 and emerging viral infections: The case for interferon lambda Ludmila Prokunina-Olsson, Noémie Alphonse, Ruth E. Dickenson, Joan E. Durbin, Jeffrey S. Glenn, Rune Hartmann, et al. (+10)
 [1] 

66 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.019 sec